健世科技-B获高瓴投资增持2085万股 约占总股份数5%

新浪网
Jul 07

香港联交所最新资料显示,6月27日,Hillhouse Fund V, L.P.(高瓴基金五期)增持健世科技-B2085万股,约占总股份数5%。从年初至今,健世科技的经导管主动脉人工瓣膜系统Ken-Valve获得NMPA上市批准,已启动全国商业化植入;经导管三尖瓣置换系统LuX-Valve Plus的全球多中心临床试验的临床数据和其在大瓣环患者群体中的优异使用结果分别在EuroPCR和New ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10